CCIA
KURA icon

Campbell & Co Investment Adviser’s Kura Oncology KURA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-117,334
Closed -$1.02M – 1183
2024
Q4 		$1.02M Buy
+117,334
New +$1.69M 0.08% 388
2024
Q2 		– Sell
-13,339
Closed -$285K – 1203
2024
Q1 		$285K Buy
+13,339
New +$259K 0.02% 925
2023
Q3 		– Sell
-17,123
Closed -$181K – 1084
2023
Q2 		$181K Buy
+17,123
New +$203K 0.03% 812
2022
Q2 		– Sell
-13,848
Closed -$223K – 802
2022
Q1 		$223K Buy
+13,848
New +$200K 0.06% 588
2020
Q4 		– Sell
-9,429
Closed -$289K – 503
2020
Q3 		$289K Buy
+9,429
New +$208K 0.22% 194

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's KURA Position: Q1 2025 in Review

Campbell & Co Investment Adviser sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 117,334 shares — an estimated $1.02M sold.

Campbell & Co Investment Adviser first reported a position in KURA in Q3 2020 and held it in 5 quarters. The position peaked at $1.02M in Q4 2024. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • Campbell & Co Investment Adviser reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 117,334 Kura Oncology shares in Q1 2025, an estimated $1.02M.
  • Campbell & Co Investment Adviser first reported a position in Kura Oncology in Q3 2020 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's Kura Oncology position peaked at $1.02M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.